Page last updated: 2024-10-22

amifostine anhydrous and Proctocolitis

amifostine anhydrous has been researched along with Proctocolitis in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Proctocolitis: Inflammation of the RECTUM and the distal portion of the COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Montana, GS1
Anscher, MS1
Mansbach, CM1
Daly, N1
Delannes, M1
Carke-Pearson, D1
Gaydica, EF1

Trials

1 trial available for amifostine anhydrous and Proctocolitis

ArticleYear
Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial.
    Cancer, 1992, Jun-01, Volume: 69, Issue:11

    Topics: Administration, Topical; Amifostine; Drug Evaluation; Humans; Intestinal Mucosa; Proctocolitis; Radi

1992